[A clinical report on modified Hyper-CVAD regimen in patients with lymphoblastic lymphoma].

Wei Shi, Yuankai Shi, Xiaohui He, Shengyu Zhou, Mei Dong, Changgong Zhang, Jian-liang Yang, Peng Liu, Yan Qin, Sheng Yang, Lin GuiPubMed 2010

Abstract

Modified Hyper-CVAD regimen was a promising regimen for the patients with LBL, and toxicity was within acceptable limits.
BibTeX
@inproceedings{shi2010clinical,
  author = {Wei Shi and Yuankai Shi and Xiaohui He and Shengyu Zhou and Mei Dong and Changgong Zhang and Jian-liang Yang and Peng Liu and Yan Qin and Sheng Yang and Lin Gui},
  title = {{[A clinical report on modified Hyper-CVAD regimen in patients with lymphoblastic lymphoma].}},
  booktitle = {PubMed},
  year = {2010},
}

Loading related content...

Figure